Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR2 | P21452 | 3/20 | 0.51 |
| ▸ | NT5E | P21589 | 1/20 | 0.48 |
| ▸ | GJB2 | P29033 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.43 |
| ▸ | CDC25B | P30305 | 5/20 | 0.43 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.42 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.41 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.41 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GJA1 | P17302 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5198380 | 1.00 | TACR2 (0.51) | TACR2NT5EGJB2TSHRPTPN1 | |
| SCHEMBL16318258 | 0.94 | TSHR (0.46) | TACR2NT5EGJB2TSHRPTPN1 | |
| SCHEMBL18241576 | 0.92 | NT5E (0.51) | TACR2NT5ETSHRPTPN1CDC25B | |
| SCHEMBL22073055 | 0.92 | TSHR (0.50) | TACR2NT5ETSHRPTPN1CDC25B | |
| SCHEMBL18744567 | 0.92 | NT5E (0.51) | TACR2NT5ETSHRPTPN1CDC25B | |
| SCHEMBL19731824 | 0.92 | NT5E (0.51) | TACR2NT5ETSHRPTPN1CDC25B | |
| SCHEMBL2482599 | 0.92 | NT5E (0.51) | TACR2NT5ETSHRPTPN1CDC25B | |
| SCHEMBL4181388 | 0.92 | NT5E (0.51) | TACR2NT5ETSHRPTPN1CDC25B | |
| SCHEMBL8225871 | 0.92 | NT5E (0.51) | TACR2NT5ETSHRPTPN1CDC25B | |
| SCHEMBL1775948 | 0.92 | NT5E (0.48) | TACR2NT5ETSHRPTPN1CDC25B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1252171-B1 | METHOD FOR PREPARING FUNCTIONALISED BETA-(1,3)-GLUCAN DERIVATIVES | GOEMAR LAB SA (FR) | 2007-08-15 | — | — | EP | disclosed |
| EP-1252171-A1 | METHOD FOR PREPARING FUNCTIONALISED BETA-(1,3)-GLUCAN DERIVATIVES | LABORATOIRES GOEMAR S.A. (FR) | 2002-10-30 | — | — | EP | disclosed |
| WO-2001057053-A1 | METHOD FOR PREPARING FUNCTIONALISED BETA-(1,3)-GLUCAN DERIVATIVES | LABORATOIRES GOEMAR (FR) | 2001-08-09 | — | — | WO | disclosed |